哈尔科因作为潜在的素抑制剂:合成,表征,DFT和分子对接研究
Prabhjot Kaur1, Neera Raghav2, Urmila Berar1
1University Institute of Engineering and Technology, Kurukshetra University, Kurukshetra, Haryana 136119, India.
International journal of biological macromolecules
|October 30, 2024
概括
新的烯基石墨烯显示出强大的素抑制作用,超过了目前的药物. 这些化合物为管理素相关的胃肠道和喉疾病提供了一个有希望的策略.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 计算化学计算化学
背景情况:
- 素在酸性环境中的过活性会导致慢性炎症和诸如声息肉和喉癌等疾病.
- 有效的氨酸抑制剂对于管理这些氨酸相关的疾病至关重要.
- 目前的治疗方法,如奥梅普拉和潘托普拉在素抑制方面存在局限性.
研究的目的:
- 为了合成和描述基于烯的新型石墨烯,作为潜在的抗素剂.
- 为了评估这些合成化合物的体外和体外效果,这些合成化合物对素的有效性.
- 为了识别具有优越素抑制活性的化合物.
主要方法:
- 合成和描述一系列基于烯的石墨烯 (化合物3a-t).
- 在实验室内进行素抑制试验,以确定百分比的抑制和IC50值.
- 分子对接和密度函数理论 (DFT) 分析以了解结合相互作用和电子性质.
主要成果:
- 与梅和潘托普拉相比,合成的石墨显示出明显更高的素抑制作用.
- 在体外查显示,在3×10−8M时,抑制率从53.19%到91.14%不等.
- 化合物3p表现出最高的强度,其IC50值为1.02 × 10−9 M.
- 分子对接揭示了强大的结合相互作用,其中化合物3p显示的相互作用能量最低 (-83.124 kcal/mol).
- DFT计算提供了关于化合物的电子结构和稳定性的见解.
结论:
- 基于蒂奥芬的石膏是有效的素抑制剂.
- 化合物3p是开发新抗素疗法的非常有前途的候选物.
- 这项研究证实了这些新型化合物的治疗素相关疾病的潜力.
- 综合体外和体内方法证实了设计的石的有效性.
相关概念视频
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...